Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.830
-0.030 (-1.05%)
At close: Aug 28, 2026, 4:00 PM EDT
2.850
+0.020 (0.71%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Boundless Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 20.21 | 17.87 | 26.59 | 23.71 | 10.95 | 34.29 |
Short-Term Investments | 52.41 | 89.71 | 125.53 | 97.05 | 55.77 | 38.74 |
Cash & Short-Term Investments | 72.63 | 107.58 | 152.11 | 120.75 | 66.72 | 73.03 |
Cash Growth | -42.88% | -29.28% | 25.97% | 80.99% | -8.65% | - |
Prepaid Expenses | 1.02 | 2.03 | 2.28 | 3.45 | 1.32 | 1.54 |
Total Current Assets | 73.65 | 109.61 | 154.39 | 124.2 | 68.04 | 74.57 |
Property, Plant & Equipment | 0.1 | 46.88 | 51.36 | 4.58 | 7.73 | 3.1 |
Long-Term Investments | - | - | - | - | - | 34.99 |
Other Long-Term Assets | - | 0.57 | 0.66 | 1.12 | 1.07 | 1.07 |
Total Assets | 73.74 | 157.06 | 206.41 | 129.89 | 76.83 | 113.72 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.05 | 1.49 | 1.27 | 2.22 | 1.4 | 1.08 |
Accrued Expenses | 6.72 | 7.88 | 6.86 | 4.94 | 3.9 | 2.08 |
Current Portion of Leases | - | 3.17 | - | 2.2 | 2.34 | 0.38 |
Other Current Liabilities | - | - | - | - | 0.09 | 0.34 |
Total Current Liabilities | 7.77 | 12.54 | 8.14 | 9.36 | 7.73 | 3.87 |
Long-Term Leases | - | 45.87 | 47.63 | - | 2.85 | - |
Other Long-Term Liabilities | - | - | - | - | 0.01 | 0.1 |
Total Liabilities | 7.77 | 58.41 | 55.77 | 9.36 | 10.58 | 3.96 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | - | 0 | 0 |
Additional Paid-In Capital | 362.92 | 358.26 | 351.99 | 8.99 | 5.38 | 2.76 |
Retained Earnings | -296.92 | -259.67 | -201.47 | -136.11 | -86.68 | -40.77 |
Comprehensive Income & Other | -0.03 | 0.06 | 0.12 | 0.04 | -0.4 | -0.18 |
Total Common Equity | 65.98 | 98.65 | 150.64 | -127.08 | -81.7 | -38.19 |
Shareholders' Equity | 65.98 | 98.65 | 150.64 | 120.54 | 66.25 | 109.76 |
Total Liabilities & Equity | 73.74 | 157.06 | 206.41 | 129.89 | 76.83 | 113.72 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | 49.04 | 47.63 | 2.2 | 5.18 | 0.38 |
Net Cash (Debt) | 72.63 | 58.55 | 104.48 | 118.56 | 61.53 | 72.66 |
Net Cash Growth | -6.46% | -43.96% | -11.87% | 92.67% | -15.31% | - |
Net Cash Per Share | 3.24 | 2.62 | 6.15 | 97.50 | 56.05 | 84.43 |
Filing Date Shares Outstanding | 22.75 | 22.41 | 22.3 | 1.25 | 1.13 | 0.86 |
Total Common Shares Outstanding | 22.47 | 22.41 | 22.3 | 1.25 | 1.13 | 0.86 |
Working Capital | 65.88 | 97.07 | 146.26 | 114.85 | 60.31 | 70.7 |
Book Value Per Share | 2.94 | 4.40 | 6.76 | -102.02 | -71.99 | -44.38 |
Tangible Book Value | 65.98 | 98.65 | 150.64 | -127.08 | -81.7 | -38.19 |
Tangible Book Value Per Share | 2.94 | 4.40 | 6.76 | -102.02 | -71.99 | -44.38 |
Machinery | 3.54 | 7.12 | 7.05 | 5.25 | 4.69 | 3.7 |
Leasehold Improvements | 0.05 | 1.05 | 0.98 | 0.05 | 0.05 | 0.2 |